Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cell death-based treatments of melanoma:conventional treatments and new therapeutic strategies
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-01-25
DOI
10.1038/s41419-017-0059-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF V600 -mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
- (2017) Max Schreuer et al. LANCET ONCOLOGY
- Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
- (2017) Paolo A Ascierto et al. LANCET ONCOLOGY
- Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
- (2017) Sydney M. Shaffer et al. NATURE
- Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
- (2016) Michael P. Smith et al. CANCER CELL
- Cancer therapy in the necroptosis era
- (2016) Z Su et al. CELL DEATH AND DIFFERENTIATION
- Molecular Pathways: Maintaining MAPK Inhibitor Sensitivity by Targeting Nonmutational Tolerance
- (2016) M. P. Smith et al. CLINICAL CANCER RESEARCH
- Future perspectives in melanoma research
- (2016) Paolo A. Ascierto et al. Journal of Translational Medicine
- Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies
- (2016) Andrew J. Colebatch et al. Oncotarget
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
- (2016) Tania Løve Aaes et al. Cell Reports
- Perspectives on Cost and Value in Cancer Care
- (2016) Leonard B. Saltz JAMA Oncology
- Metastatic Melanoma – A Review of Current and Future Treatment Options
- (2015) E Maverakis et al. ACTA DERMATO-VENEREOLOGICA
- MITF Modulates Therapeutic Resistance through EGFR Signaling
- (2015) Zhenyu Ji et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gender Disparity and Mutation Burden in Metastatic Melanoma
- (2015) Sameer Gupta et al. JNCI-Journal of the National Cancer Institute
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of Caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis
- (2015) M F Brown et al. Cell Death & Disease
- Gender Disparity and Mutation Burden in Metastatic Melanoma
- (2015) Sameer Gupta et al. JNCI-Journal of the National Cancer Institute
- A Gender Factor in Shaping T-Cell Immunity to Melanoma
- (2015) Roxana S. Dronca et al. Frontiers in Oncology
- Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1 and Oxidative Phosphorylation in Melanoma
- (2014) Y. N. V. Gopal et al. CANCER RESEARCH
- Complete Loss of PTEN Protein Expression Correlates with Shorter Time to Brain Metastasis and Survival in Stage IIIB/C Melanoma Patients with BRAFV600 Mutations
- (2014) A. D. Bucheit et al. CLINICAL CANCER RESEARCH
- Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
- (2014) Kent Shih et al. DRUGS
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- A stress-induced early innate response causes multidrug tolerance in melanoma
- (2014) D Ravindran Menon et al. ONCOGENE
- Receptor Interactive Protein Kinase 3 Promotes Cisplatin-Triggered Necrosis in Apoptosis-Resistant Esophageal Squamous Cell Carcinoma Cells
- (2014) Yang Xu et al. PLoS One
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Incidence and Survival for Merkel Cell Carcinoma in Queensland, Australia, 1993-2010
- (2014) Danny R. Youlden et al. JAMA Dermatology
- Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
- (2014) Katherine Woods et al. Frontiers in Oncology
- Immunotherapy of melanoma
- (2013) John B.A.G. Haanen EJC SUPPLEMENTS
- Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
- (2013) Arjen Joosse et al. JOURNAL OF CLINICAL ONCOLOGY
- Melanoma Epidemic: An Analysis of Six Decades of Data From the Connecticut Tumor Registry
- (2013) Alan C. Geller et al. JOURNAL OF CLINICAL ONCOLOGY
- Chloroquine Promotes Apoptosis in Melanoma Cells by Inhibiting BH3 Domain–Mediated PUMA Degradation
- (2013) Alexander J. Lakhter et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cutaneous melanoma
- (2013) Alexander MM Eggermont et al. LANCET
- BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
- (2013) Rahul Roychoudhuri et al. NATURE
- Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
- (2013) Zhenyu Cai et al. NATURE CELL BIOLOGY
- Targeting autophagy as a potential therapeutic approach for melanoma therapy
- (2013) He Liu et al. SEMINARS IN CANCER BIOLOGY
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
- (2013) E. M. Van Allen et al. Cancer Discovery
- Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage
- (2012) Nicola Ivan Orlotti et al. Autophagy
- Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine
- (2012) Jindřiška Hammerová et al. BIOLOGICAL CHEMISTRY
- Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14
- (2012) Jonathan W. Biggers et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Autophagy Is a Protective Mechanism for Human Melanoma Cells under Acidic Stress
- (2012) Maria Lucia Marino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials
- (2012) Arjen Joosse et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
- (2012) Antoni Ribas et al. Journal of Translational Medicine
- Tumor immunity times out: TIM-3 and HMGB1
- (2012) Daolin Tang et al. NATURE IMMUNOLOGY
- DNA damage checkpoints in stem cells, ageing and cancer
- (2012) Tobias Sperka et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of acquired resistance to ERK1/2 pathway inhibitors
- (2012) A S Little et al. ONCOGENE
- Photodynamic treatment induces cell death by apoptosis or autophagy depending on the melanin content in two B16 melanoma cell lines
- (2012) AGNÈS SPARSA et al. ONCOLOGY REPORTS
- Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation
- (2012) N. Patsoukis et al. Science Signaling
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
- (2010) Luca Sigalotti et al. Journal of Translational Medicine
- Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study
- (2010) Paola Matarrese et al. Molecular Cancer
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
- (2010) Georgia Hatzivassiliou et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
- (2010) M L Marino et al. Cell Death & Disease
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Expression of Sorafenib Targets in Melanoma Patients Treated with Carboplatin, Paclitaxel and Sorafenib
- (2009) L. Jilaveanu et al. CLINICAL CANCER RESEARCH
- Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
- (2009) John R. Eckardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Activity of dasatinib against L576P KIT mutant melanoma: Molecular, cellular, and clinical correlates
- (2009) S. E. Woodman et al. MOLECULAR CANCER THERAPEUTICS
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
- (2008) Nele Müller-Hermelink et al. CANCER CELL
- Polygonatum cyrtonema lectin induces apoptosis and autophagy in human melanoma A375 cells through a mitochondria-mediated ROS–p38–p53 pathway
- (2008) Bo Liu et al. CANCER LETTERS
- Tumour cell survival signalling by the ERK1/2 pathway
- (2008) K Balmanno et al. CELL DEATH AND DIFFERENTIATION
- Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
- (2008) Henrike E. Karim-Kos et al. EUROPEAN JOURNAL OF CANCER
- The advantage of women in cancer survival: An analysis of EUROCARE-4 data
- (2008) A. Micheli et al. EUROPEAN JOURNAL OF CANCER
- Frequent p16-Independent Inactivation of p14ARF in Human Melanoma
- (2008) Daniel E. Freedberg et al. JNCI-Journal of the National Cancer Institute
- Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells
- (2008) M. Zheng et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now